Filter posts

BayBio Op-ed featured in Xconomy

Gail Maderis, President & CEO of BayBio, recently discussed the strength of Northern California’s biotechnology …

Choose Your Own Adventure – The Private Biotech Crossroads

It is a known fact within the private company biopharma universe that the days of …

BIO Investor Forum - Raring to Go: The Race to Treat Ultra-Rare Diseases

The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering …

Kinase Drug Development - Making Progress

The kinase inhibition field has had plenty of ups and downs and over the last …

BIO Investor Forum: The New Kids on the Biotech Block

Where should biotech start-ups look for funding in the venture capital desert that is becoming …

Cancer Stem Cell Therapy: Real Or Just Hype?

Also known as tumor-initiating cells, cancer stem cells (CSC) have unique capability endemic to stem …

#BIF2012 Company Snapshot: Chimerix

Our next Company Snapshot for next week’s BIO Investor Forum is Chimerix. They will be …

#BIF2012 Company Snapshot: Profil Institute for Translational Medicine

For the next Company Snapshot for the BIO Investor Forum, we’ve spoken with one of …

2012 BIO Investor Forum: Presenting Companies Making News

Need a heart valve? Perhaps a bit more cartilage in your knees? Better yet, how …

A Start-Up Model Worthy of Consideration

Biotech LLCs are getting a lot of attention lately, and perhaps rightfully so. The Wall …